|Outcome and prognostic factors of malaria-associated acute kidney injury requiring hemodialysis: A single center experience.|
|Jump to Full Text|
|PMID: 22279340 Owner: NLM Status: In-Data-Review|
|Acute kidney injury (AKI) is one of the most dreaded complications of severe malaria. We carried out prospective study in 2010, to describe clinical characteristics, laboratory parameters, prognostic factors, and outcome in 59 (44 males, 15 females) smear-positive malaria patients with AKI. The severity of illness was assessed using Acute Physiology and Chronic Health Evaluation (APACHE) II, Sequential Organ Failure Assessment (SOFA) score, Multiple Organ Dysfunction Score (MODS), and Glasgow Coma Scale (GCS) scores. All patients received artesunate and hemodialysis (HD). Mean age of patients was 33.63 ± 14 years. Plasmodium falciparum malaria was seen in 76.3% (n = 45), Plasmodium vivax in 16.9% (n = 10), and mixed infection in 6.8% (n = 4) patients. Presenting clinical features were fever (100%), nausea-vomiting (85%), oliguria (61%), abdominal pain/tenderness (50.8%), and jaundice (74.5%). Mean APACHE II, SOFA, MODS, and GCS scores were 18.1 ± 3, 10.16 ± 3.09, 9.71 ± 2.69, and 14.15 ± 1.67, respectively, all were higher among patients who died than among those who survived. APACHE II ≥20, SOFA and MODS scores ≥12 were associated with higher mortality (P < 0.05). 34% patients received blood component transfusion and exchange transfusion was done in 15%. Mean number of HD sessions required was 4.59 ± 3.03. Renal biopsies were performed in five patients (three with patchy cortical necrosis and two with acute tubular necrosis). 81.3% of patients had complete renal recovery and 11.8% succumbed to malaria. Prompt diagnosis, timely HD, and supportive therapy were associated with improved survival and recovery of kidney functions in malarial with AKI. Mortality was associated with higher APACHE II, SOFA, MODS, GCS scores, requirement of inotrope, and ventilator support.|
|V B Kute; P R Shah; B C Munjappa; M R Gumber; H V Patel; S H Jain; D P Engineer; V V Sai Naresh; A V Vanikar; H L Trivedi|
|Type: Journal Article|
|Title: Indian journal of nephrology Volume: 22 ISSN: 1998-3662 ISO Abbreviation: Indian J Nephrol Publication Date: 2012 Jan|
|Created Date: 2012-01-26 Completed Date: - Revised Date: -|
Medline Journal Info:
|Nlm Unique ID: 8914356 Medline TA: Indian J Nephrol Country: India|
|Languages: eng Pagination: 33-8 Citation Subset: -|
|Department of Nephrology and Clinical Transplantation, Institute of Kidney Diseases and Research Center, Institute of Transplantation Sciences, IKDRC-ITS, Ahmedabad, India.|
|APA/MLA Format Download EndNote Download BibTex|
Journal ID (nlm-ta): Indian J Nephrol
Journal ID (publisher-id): IJN
Publisher: Medknow Publications & Media Pvt Ltd, India
Copyright: © Indian Journal of Nephrology
Print publication date: Season: Jan-Feb Year: 2012
Volume: 22 Issue: 1
First Page: 33 Last Page: 38
PubMed Id: 22279340
Publisher Id: IJN-22-33
|Outcome and prognostic factors of malaria-associated acute kidney injury requiring hemodialysis: A single center experience|
|V. B. Kuteaff1|
|P. R. Shahaff1|
|B. C. Munjappaaff1|
|M. R. Gumberaff1|
|H. V. Patelaff1|
|S. H. Jainaff1|
|D. P. Engineeraff1|
|V. V. Sai Nareshaff1|
|A. V. Vanikar1|
|H. L. Trivediaff1|
|Department of Nephrology and Clinical Transplantation, Institute of Kidney Diseases and Research Center, Institute of Transplantation Sciences, IKDRC-ITS, Ahmedabad, India
1Department of Pathology, Laboratory Medicine, Transfusion Services and Immunohematology, IKDRC-ITS, Ahmedabad, India
|Correspondence: Address for correspondence: Dr. V. B. Kute, Department of Nephrology and Clinical Transplantation, Institute of Kidney Diseases & Research Centre (IKDRC), Institute of Transplantation Sciences (ITS), Civil Hospital Campus, Asarwa, Ahmedabad 380016, Gujarat, India. E-mail: email@example.com
Malaria is a major public health problem in tropical countries. About 500 million people suffer from malaria, leading to death in 1 to 3 million cases. Acute kidney injury (AKI) is one of the most dreaded complications of severe malaria. The overall prevalence of AKI in falciparum malaria varies between <1 and 60%, with the mortality rate up to 45%.[1–4] AKI occurs commonly in Plasmodium falciparum (PF) malaria and rarely in Plasmodium vivax (PV) malaria.[5–7] Malaria is an important cause of multiple organ failure; mortality rate is 6.4% when one or fewer organs fail, but increases to 48.8% with failure of two or more organs. However, outcomes are better than for similar degrees of organ failure in sepsis. Prompt and accurate diagnosis of malaria is needed for implementation of appropriate treatment to reduce associated morbidity and mortality. The management of malaria-induced AKI includes appropriate antimalarials (parenteral artesunate or quinine), fluid electrolyte management, supportive therapy, avoidance of nephrotoxic drugs, and renal replacement therapy (RRT) at the earliest.[1, 9] Hemodialysis (HD) is effective for malaria-associated AKI.[10, 11]
We carried out prospective single-center study to describe the clinical characteristics, laboratory parameters, prognostic factors, and outcome in patients with malaria with AKI who underwent HD.
All 50 patients with malaria-associated AKI seen at our center in 2010 were included in the study. The diagnosis of malaria was confirmed by direct visualization of the parasite in Giemsa-stained peripheral blood smears. In addition, once a diagnosis has been established and treatment has been initiated, serial examinations permit monitoring of the parasitological response. Clinical history and assessment were recorded in all the study patients and all other known etiological causes of fever and jaundice were excluded by relevant investigations. Other causes of jaundice excluded by absence of evidence of exposure to hepatotoxic drugs and absence of clinical or serological evidence of infective etiology (like viral hepatitis, leptospirosis). All the patients were subjected to complete hemogram. Urine samples were examined for routine and microscopy examinations. Serum was tested for sodium, potassium, alkaline phosphatase, alanine aminotransaminase, bilirubin, lactic acid dehydrogenase, and glucose 6-phosphate dehydrogenase. Serological tests for Human Immunodeficiency Virus and hepatitis B and C were performed. Estimation of blood sugar, coagulation profile for disseminated intravascular coagulation (DIC), and arterial blood gas analysis were carried out when indicated. Chest x-ray and ultrasonography (USG) of abdomen were recorded in all the patients. AKI was defined as serum creatinine (SCr) of >3 mg/dl and urine output <400 ml/24 hours, with normal kidney size on USG as per World Health Organization (WHO) definition. Jaundice was defined as icteric sclera and/ or total bilirubin levels >3 mg/dl. The severity of illness was assessed using APACHE II, SOFA, MODS, and GCS scores.[13–16] The patients were managed using antimalarial drugs, fluid replacement, and RRT. All patients received artesunate 2.4 mg/kg intravenously, followed by 2.4 mg/kg at 12 and 24 hours, followed by 2.4 mg/kg once daily for a total of 7 days and doxycycline (adults: 100 mg orally twice daily; children: 2.2 mg/kg [up to 100 mg] orally twice daily). In absence of parasitological or clinical response to parenteral artesunate, patients received quinine 20 mg salt/kg body weight through intravenous (IV) infusion in 5 percent dextrose over 4 hours, then 10 mg/kg body weight every 8 hour for 5 to 7 days. IV 25% dextrose injections were administered to prevent and treatment of hypoglycemia. Broad-spectrum antibiotic treatment (IV ceftriaxone 1 g BD) was given initially until a bacterial infection (notably Salmonella) was excluded.[17–19] Supportive measures (e.g., antipyretics, oxygen, ventilatory support, cardiac monitoring, and pulse oximetry) were instituted as needed. RRT was initiated for fluid overload, hyperkalemia, clinical evidence of uremia, metabolic acidosis, rapidly increasing SCr level, blood urea nitrogen (BUN)>100 mg/dl, and SCr >4 to 5 mg/dl. RRT was initiated prior to the development of overt symptoms and signs of renal failure due to malaria.[1, 3–11, 17] The HD prescription included a polysulfone membrane dialyzer with surface area 1.3 to 1.8 m2, a blood flow rate of 200 to 300 ml/ min, and a dialysate flow rate of 500 ml/min against a 35 mEq/l bicarbonate bath. Dialysate potassium was adjusted individually. Heparin-free (in most of patients) intermittent HD was provided on alternate days through temporary femoral/jugular catheter for 4 hours and continuous renal replacement therapies (CRRT) were done in hemodynamically unstable patients. RRT was usually continued until the patient manifested evidence of recovery of kidney function. In oliguric patients, the primary manifestation of recovery of kidney function was an increase in urine output. In patients who were nonoliguric, recovery of kidney function was manifested by a progressive decline in SCr concentration after initial attainment of stable values (assessed daily during CRRT or predialysis in patients managed with intermittent HD), despite a constant dose of renal support. Fluid requirements were assessed individually and fluid resuscitation based on estimated deficit. Many patients with oliguria who were dehydrated on admission received fluid challenge. They received fluid up to 20 ml/kg of 0.9% saline infused over 60 minutes. To prevent fluid overload, auscultation of the lungs and jugular venous pressure measurements were done. Careful attention was given toward fluid and electrolyte requirements during diuretic phase. In addition, repeated estimation of Na, K, and bicarbonate was done. Patients with severe malaria with clinically significant DIC were given fresh whole blood transfusions, vitamin K, and fresh frozen plasma. Blood transfusion was reserved for patients with hemoglobin ≤7 g/dl.[8, 12] 10 ml/kg of packed red blood cells or 20 ml/ kg of whole blood was transfused during HD. In addition, support of erythropoiesis in the form of replacement of folic acid and iron was instituted since many patients were malnourished. Exchange transfusion was done for patients with parasite density of >10 percent with end organ complications, serum bilirubin >25 mg/ dl.[3, 17, 20–22] Renal biopsy was performed when oliguria/heavy proteinuria (>3 g/day) or hematuria persisted for three weeks.
Data entry and statistical analysis were performed using the SPSS 12.0 software. The continuous variables were presented as mean ± standard deviation and assessed by analysis of Mann–Whitney U-test to identify the differences between groups, with statistical significance set at P < 0.05. Univariate and multivariate analysis were performed using SPSS version-12. Multivariate analysis of variance (MANOVA) was performed using SPSS version-12. Analysis of each individual-dependent variable, using Bonferroni-adjusted alpha level, shows that there was no contribution of the dependent variables. We considered the values for the Wilks’ Lambda and Pillai's Trace for robustness of MANOVA. Levene's Test of Equality of Error Variances was performed.
Baseline characteristics of the study patients are shown in Table 1. Comparison of patients who survived and died is shown in Table 2. The mean age of the 59 patients was 33.63 ± 14.6 years (range, 6-75 years); 44 (74.5 %) were males and 15(25.5%) were females. PF malaria was seen in 76.3% (n = 45), PV in 16.9% (n = 10), and mixed infection in 6.8% (n = 4) patients. Presenting clinical features were fever (100%), nausea-vomiting (85%), oliguria (61%), abdominal pain/tenderness (50.8%), jaundice (74.5 %), dyspnea (30.5%), diarrhea (15.2%), altered sensorium (10%), and convulsions (8.4%).The time between onset of symptoms and admission to the hospital for AKI ranged from 7 to 14 days (median, 10 days). Hyponatremia, usually asymptomatic, was observed in 71% (n = 42) of patients.
The mean APACHE II score was 18.1 ± 3, (9-32); the mean SOFA score was 10.16 ± 3.09, (4-17); the mean MODS score was 9.71 ± 2.69, (4-16); and the mean GCS score was 14.15 ± 1.67, (8-15), all were higher, indicating more severe abnormalities among the patients who died than among those who survived as shown in Tables 1 and 2. SOFA score <12 were associated with a low mortality rate (41 patients, 0 deaths), whereas score ≥12 showed poorer outcome (18 patients, 7 deaths, P < 0.0001; relative risk, 0.19; 95% confidence interval, 0.10-0.34). MODS score <12 were associated with a low mortality rate (43 patients, 0 deaths), whereas score ≥12 showed a worse outcome (16 patients, 7 deaths, P < 0.001; relative risk, 0.19; 95% confidence interval, 0.10–0.34). APACHE II score <20 were associated with a low mortality rate (42 patients, 0 deaths), whereas score ≥20 showed a worse outcome (17 patients, 7 deaths, P < 0.001; relative risk, 0.21; 95% confidence interval, 0.11–0.37). On multivariate analysis, statistically significant predictors of outcome were APACHE II score (P = 0.0004), SOFA score (P = 0.0003), MODS score (P = 0.002), GCS score (P = 0.00002), and Lactate dehydrogenase (LDH) level (P = 0.00001).
Cerebral malaria was observed in eight patients, and three of them survived. Approximately 34% (n = 20) patients received blood component transfusion. HD was performed in 57 patients and CRRT was performed in two patients. Additional peritoneal dialysis was initially performed in two pediatric patients. Mean number of HD sessions required was 4.59 ± 3.03 (range, 1-15). All patients received artesunate and additional quinine was required in 10 (16.9%), exchange transfusion was done in 15% (n = 9) patients and 10% (n = 6) of these survived. Renal biopsies were performed in 5 patients, of whom 60% (n = 3) had patchy cortical necrosis and 40% (n = 2) had acute tubular necrosis (ATN) with mesangial proliferative glomerulonephritis without any immune deposits. 81.3% (n = 48) of the patients had complete recovery with normal renal function (SCr <1.4 mg/ dl), 5% (n = 3) had incomplete recovery (SCr, 1.5-3 mg/dl) and remained on conservative management, 1.6% (n = 1) ended up as chronic renal failure and continued on maintenance HD, and 11.8% (n = 7) succumbed to malaria due to multiorgan dysfunction syndrome (MODS). The most common adverse effects associated with artesunate included nausea, vomiting, anorexia, and dizziness, although these may be due to malaria rather than drug adverse effects. Factors related to AKI in vivax malaria were heavy parasitemia, hyperbilirubinemia, volume depletion, hypercatabolic state, intravascular hemolysis, and sepsis.
Our analysis of malaria patients with AKI reveals that renal failure was observed in adults and more common in males. This could be explained by more outdoor activities of males in Asian countries as compared with females. Most common presentation was jaundice with AKI (75%). AKI occurs commonly with jaundice, thrombocytopenia, and rarely with cerebral malaria. AKI was usually seen in early second week and is oliguric in 61% of cases. The etiology of AKI was usually multifactorial due to hyperbilirubinemia, intravascular hemolysis, hyperparasitemia, volume depletion, hypoxia, shock, pigment nephropathy, DIC, and sepsis.[1–9, 23–27] The cascade of inflammatory cytokine activation leading specifically to renal damage remains enigmatic. The overall mortality rate among those with kidney injury ranges from 15 to 50% in different series.[7, 8, 28, 29] Low mortality (11.8%) in our study of malaria with AKI despite of having jaundice in 75% is due to prompt diagnosis, timely HD, exchange transfusion, and supportive therapy.
In earlier reports, almost all cases of malarial AKI were observed in adults and more common in males. AKI is associated with the jaundice in more than 75% patients. Similar findings are noted in our study. The effect of associated AKI on mortality in cerebral malaria patients indicated that mortality was as high as 39.5% when associated with AKI, whereas it was only 13.9% when unassociated with AKI.
Hyponatremia, usually asymptomatic, is observed in 71% (n = 42) of the patients. Hyponatremia in adults with severe malaria is common and associated with preserved consciousness and decreased mortality. It likely reflects continued oral hypotonic fluid intake in the setting of hypovolemia and requires no therapy beyond dehydration.
The incidence of jaundice in falciparum malaria has been reported to be between 2 and 57%.[30, 34, 35] AKI associated with jaundice had high mortality in comparison with nonjaundiced AKI patients. Jaundice is probably associated with toxicity to tubular cells with more risk of development of acute tubular necrosis. In patients with falciparum malaria with jaundice, 40% succumbed to the disease. Indirect hyperbilirubinemia from RBC destruction is the most common form of jaundice reported in malaria.[37, 38] Some patients with falciparum malaria have direct hyperbilirubinemia and elevated hepatic enzymes. In our study, 75% patients had jaundice as a presenting symptom, which is in accordance to the findings reported in other studies.
A number of investigators have recommended that exchange transfusion be considered solely for patients with high-grade parasitemia.[3, 5, 20–23] The rationale for exchange transfusion therapy is based on rapid reduction in the parasite load by direct removal, decreased risk of severe intravascular hemolysis and its consequences, improved rheology with transfused blood and reduced microcirculatory sludging, and improved oxygen-carrying capacity with transfused erythrocytes. However, the WHO guidelines indicate that it is not possible to make any recommendations regarding the use of exchange transfusion based on the available evidence. The Centers for Disease Control (CDC) recommends consideration of exchange transfusion for patients with parasite density of >10% with end organ complications.
APACHE II, SOFA, and MODS scores have been used in malaria for determining severity of malaria.[8, 40–41] MODS score ≥16 was associated with significantly longer disease duration. Thus, this score might provide a predictive value for morbidity in PF malaria. The MODS is simple and easy to apply and needs a recording time of less than three minutes. Thus, this score might provide a quantitative approach for determining severity in PF malaria. High APACHE II score, deep unconsciousness, AKI, and acidemia were identified as poor prognostic factors in cerebral malaria patients. With the cut-off point at a score of 24, the APACHE II score stratified the patients’ mortality outcome with 95.8% accuracy. Increasing SOFA scores indicated worse outcomes in study of severe falciparum malaria. SOFA score <10 were associated with a low mortality rate, whereas scores >10 showed a significantly worse outcome. APACHE II score ≥20, SOFA and MODS scores ≥12 were associated with higher mortality in our study. These score can be used for prognosis in malaria with AKI. These scores can help us for better stratification of patients for better and intensive managements to improve outcome. In our study, on univariate and multivariate analysis, statistically significant predictors of outcome were APACHE II, SOFA, MODS, GCS scores, and LDH level.
There is no direct pathogenic linkage between vivax malaria and AKI, but the associated conditions such as heavy parasitemia, hypercatabolic state, volume depletion, hyperbilirubinemia, intravascular hemolysis, sepsis, and DIC can contribute to AKI. Hence, despite the association, cause and effect relationships remain doubtful.[5, 23, 42] Hyperbilirubinemia may contribute to reduction in total peripheral vascular resistance and in renal blood flow due to left ventricular dysfunction. More studies are required to address factors related to AKI in vivax malaria. Acute cortical necrosis (ACN) has rarely been reported in patients with AKI due to malaria.[44–47] The possible pathogenetic factors in patients with ACN were the renal damage through renal hypoperfusion or endothelial injury through release of various circulating substances (intravascular hemolysis, sepsis, and pancreatitis). It should be suspected in patients with AKI who have a prolonged phase of oligoanuria.[44–48]
These findings are of importance for clinicians in prognosticating their patients with AKI due to malaria. Future studies representing a large population with the full spectrum of malaria patients in different geographical areas will determine the usefulness of this scoring method for both clinicians and researchers and recommendation for adjunct exchange transfusion.
Malaria is an important cause of AKI in Asia and particularly in tropical areas. Prompt diagnosis, timely HD, and supportive therapy are associated with improved survival and recovery of kidney functions in malarial with AKI. Mortality was associated with higher APACHE II, SOFA, MODS, GCS scores, requirement of inotrope, and ventilator support.
Source of Support: Nil
Conflict of Interest: None declared.
|1.||Mishra SK,Das BS. Malaria and acute kidney injurySemin NephrolYear: 20082839540818620962|
|2.||Sheehy TW,Reba RC. Complications of Falciparum malaria and their treatmentAnn Inter MedYear: 1967668079|
|3.||Kanodia KV,Shah PR,Vanikar AV,Kasat P,Gumber M,Trivedi HL. Malaria induced acute renal failure: A single center experienceSaudi J Kidney Dis TransplYear: 20102110889121060178|
|4.||Eiam-Ong S,Sitprija V. Falciparum malaria and the kidney: A model of inflammationAM J Kidney DisYear: 199832361759740151|
|5.||Prakash J,Singh AK,Kumar NS,Saxena RK. Acute renal failure in Plasmodium vivax malariaJ Assoc Physicians IndiaYear: 200351265712839348|
|6.||J Prakash,AK Singh. Acute renal failure in Malaria: Changing trendsIndian J NephrolYear: 2002121137|
|7.||Mehta KS,Halankar AR,Makwana PD,Torane PP,Satija PS,Shah VB. Severe acute renal failure in malariaJ Postgrad MedYear: 20014724611590286|
|8.||Krishnan A,Karnad DR. Severe Falciparum malaria: An important cause of multiple organ failure in Indian intensive care unit patientsCrit Care MedYear: 20033122788414501957|
|9.||Das BS. Renal failure in malariaJ Vector Borne DisYear: 2008458397 Review. 18592837|
|10.||Wilairatana P,Westerlund EK,Aursudkij B,Vannaphan S,Krudsood S,Viriyavejakul P,et al. Treatment of malarial acute renal failure by hemodialysisAm J Trop Med HygYear: 199960233710072141|
|11.||Trang TT,Phu NH,Vinh H,Hien TT,Cuong BM,Chau TT,et al. Acute renal failure in patients with severe Falciparum malariaClin Infect DisYear: 199215874801445988|
|12.||WHO, WHO releases new malaria guidelines for treatment and procurement of medicinesLast cited on 2011 Jan 25 Available from: http://ww.who.int/malaria/world_malaria_report_2010/en/index.html.|
|13.||Knaus WA,Draper EA,Wagner DP,Zimmerman JE. APACHE II: A severity of disease classi-fication systemCrit Care MedYear: 198513818293928249|
|14.||Vincent JL,Mendonca A,Cantraine F,Moreno R,Takala J,Suter PM,et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective studyCrit Care MedYear: 19982617938009824069|
|15.||Weiler Th,Baldering HJ,Heinrichs W,Schmitz JE. Quality assurance in intensive care medicine.Results of a multicenter study in GermanyAnästhesiol Intensivmed SchmerztherYear: 1997323725|
|16.||Helbok R,Dent W,Nacher M,Treeprasertsuk S,Krudsood S,Wilairatana P,et al. Use of the multi-organ dysfunction score as a tool to discriminate different levels of severity in uncomplicated Plasmodium Falciparum malariaAm J Trop Med HygYear: 200368372512685647|
|17.||Talor TE,Daily JP,Baron Elinor L. Treatment of severe Falciparum malariaLast cited on 2011 Jan 25 Available from http://www.uptodate.com.|
|18.||Berkley J,Mwarumba S,Bramham K,Lowe B,Marsh K. Bacteraemia complicating severe malaria in childrenTrans R Soc Trop Med HygYear: 199993283610492760|
|19.||Bronzan RN,Taylor TE,Mwenechanya J,Tembo M,Kayira K,Bwanaisa L,et al. Bacteremia in Malawian children with severe malaria: Prevalence, etiology, HIV coinfection, and outcomeJ Infect DisYear: 200719589590417299721|
|20.||Riddle MS,Jackson JL,Sanders JW,Blazes DL. Exchange transfusion as an adjunct therapy in severe Plasmodium Falciparum malaria: A meta-analysisClin Infect DisYear: 2002341192811941545|
|21.||Phillips P,Nantel S,Benny WB. Exchange transfusion as an adjunct to the treatment of severe Falciparum malaria: Case report and reviewRev Infect DisYear: 199012110082267486|
|22.||Zucker JR,Campbel CC. Malaria. Principles of prevention and treatmentInfect Dis Clin North AmYear: 19937547678254159|
|23.||Jha V,Chugh KS. Community-acquired acute kidney injury in AsiaSemin NephrolYear: 2008283304718620956|
|24.||Prakash J,Gupta A,Kumar O,Rout SB,Malhotra V,Srivastava PK. Acute renal failure in Falciparum malaria-increasing prevalence in some areas of India-a need for awarenessNephrol Dial TransplantYear: 19961124168671773|
|25.||Rajapurkar MM. Renal involvement in malariaJ Postgrad MedYear: 19944013248699378|
|26.||Ehrich JH,Eke FU. Malaria-induced renal damage: Facts and mythsPediatr NephrolYear: 2007226263717205283|
|27.||Sakhuja V,Sud K. Acute renal failure in the tropicsSaudi J Kidney Dis TransplYear: 199892476018408297|
|28.||WHO. Severe Falciparum malariaTrans R Soc TropMed HygYear: 20001s190|
|29.||Habte B. Acute renal failure due to Falciparum malariaRen FailYear: 1990121592236718|
|30.||Mohanty S,Mishra SK,Pati SS,Pattnaik J,Das BS. Complications and mortality patterns due to Plasmodium Falciparum malaria in hospitalized adults and children, Rourkela, Orissa, IndiaTrans R Soc Trop Med HygYear: 200397697012886808|
|31.||Mishra SK,Dietz K,Mohanty S,Pati SS. Influence of acute renal failure in patients with cerebral malaria: A hospitalbased study from IndiaTrop DoctYear: 200737103417540094|
|32.||Miller LH,Makaranond P,Sitprija V,Suebsanguan C,Canfield CJ. Hyponatraemia in malariaAnn Trop Med ParasitolYear: 196761265794867548|
|33.||Hanson J,Hossain A,Charunwatthana P. Hyponatremia in severe malaria: Evidence for an appropriate anti-diuretic hormone response to hypovolemiaAm J Trop Med HygYear: 200980141519141852|
|34.||Mehta SR. Falciparum malaria-210 casesJ Assoc Physicians IndiaYear: 198634119203519571|
|35.||Nand N,Aggarwal H,Sharma M,Singh M. Systemic Manifestations of MalariaJ Indian Acad Clin MedYear: 2001218994|
|36.||Pati SS,Mishra SK,Mohanty S,Patnaik JK,Das BS. Influence of renal impairment on plasma concentrations of conjugated bilirubin in cases of Plasmodium Falciparum malariaAnn Trop Med ParasitolYear: 200397581614511556|
|37.||Ahsan T,Ali H,Bkaht SF,Ahmad N,Farooq MU,Shaheer A,et al. Jaundice in Falciparum malaria; Changing trends in clinical presentation-a need for awarenessJ Pak Med AssocYear: 2008586162119024133|
|38.||World Health Organization: Severe and complicated malariaTrans Royal Soc Trop Med HygYear: 199084165|
|39.||Willairatana P,Looaresuwan S,Charoenlarp P. Liver profile changes and complications in jaundiced patients with Falciparum malariaTrop Med ParasitolYear: 1994452983027716391|
|40.||Helbok R,Dent W,Nacher M,Treeprasertsuk S,Krudsood S,Wilairatana P,et al. Use of the multi-organ dysfunction score as a tool to discriminate different levels of sevAm J Trop Med HygYear: 200368372512685647|
|41.||Wilairatana P,Looareesuwan S. APACHE II scoring for predicting outcome in cerebral malariaJ Trop Med HygYear: 199598256607636922|
|42.||Chung BH,Lee SW,Lee SE,Hwang TJ,Shin HS. Predictors of Plasmodium vivax malaria-induced nephropathy in young Korean menNephron Clin PractYear: 2008110c172718953180|
|43.||Green J,Beyar R,Bomzon L,Finberg JP,Better OS. Jaundice, the circulation and the kidneyNephronYear: 198437145526738765|
|44.||Chugh KS,Jha V,Sakhuja V,Joshi K. Acute renal cortical necrosis-A study of 113 patientsRen FailYear: 19941637478184145|
|45.||Chugh KS,Singhal PC,Kher V,Gupta VK,Malik GH,Narayan G,et al. Spectrum of acute cortical necrosis in Indian patientsAm J Med SciYear: 198328610206869412|
|46.||Sakhuja V,Chugh KS. Renal cortical necrosisInt J Artif OrgansYear: 1986914563733238|
|47.||Baliga KV,Narula AS,Khanduja R. Acute cortical necrosis in Falciparum malaria: An unusual manifestationRen FailYear: 200830461318569922|
|48.||Singhal MK,Arora P,Kher V,Pandey R,Gulati S,Gupta A. Acute cortical necrosis in Falciparum malaria: An unusual cause of end-stage renal diseaseRen FailYear: 19971949149154667|
Keywords: Acute kidney injury, hemodialysis, jaundice, malaria, outcome.
Previous Document: Interaction between gentamicin and mycophenolate mofetil in experimentally induced pyelonephritis.
Next Document: Monthly cost of three exchanges a day peritoneal dialysis is same as of thrice a week hemodialysis i...